Think Bioscience Inc.
The University of ĢӰ Connection
is a Boulder-based synthetic biology company with strong roots at ĢӰ Boulder. The company was spun out of 's lab (ĢӰ Boulder Department of Chemical and Biological Engineering and BioFrontiers Institute), where its foundational technology, leveraging microbial systems to discover small-molecule drugs for previously “undruggable” targets, was developed. Its lead programs, including inhibitors of PTP1B, emerged directly from this academic research.
Funding Status and Investment Opportunities
- Industry Applications: Health and Wellness, Biotech, Therapeutics
- Funding Round: Series B
- Contact for Investment Inquiries: , jfox@thinkbioscience.com
In the News
- ĢӰ BioScience Association announces eight ĢӰ Boulder companies will present at 2026 Rocky Mountain Life Sciences Investor & Partnering Conference (2026, CBSA)
- Think Bioscience raises $55M in oversubscribed Series A (2026)
- Think Bioscience, a ĢӰ Boulder spinout, raises $26M to find ‘pockets’ for drug therapies (2024)
- Six ĢӰ Boulder startups selected to present at the Rocky Mountain Life Science Investor Conference (2024)
- Jerome Fox elevated to senior member of prestigious National Academy of Inventors (2024)
- ĢӰ Boulder spinout Think Bioscience raises $17M to target undruggable proteins (2022)
Venture Partners Programs
- Destination Startup (2022)
- Lab Venture Challenge(2020)
- Intellectual Property Management (2018)
Technology Development Funding
U.S. National Science Foundation (NSF)
This page was last updated on May 19, 2025. Please email vpnews@colorado.edu for corrections or updates
The Insider Investor eNewsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard,senior marketing and communications specialist for Venture Partners at ĢӰ Boulder.
For media inquiries, please visit .